PT Anabatic Technologies Tbk (IDX:ATIC)

Revance Therapeutics Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	949,298	865,945	1,157,681	907,622	1,852,289	1,331,333
Market Cap Growth	21.69%	-25.20%	27.55%	-51.00%	39.13%	-10.16%
Enterprise Value	1,835,548	2,229,914	3,256,267	2,425,348	3,624,752	3,136,559
Last Close Price	410.00	374.00	500.00	392.00	800.00	575.00
PE Ratio	4.95	4.72	4.92	13.20	-	-
Forward PE	-	10.82	10.82	10.82	10.82	10.82
PS Ratio	0.11	0.10	0.11	0.12	0.29	0.22
PB Ratio	1.44	1.44	2.94	5.61	25.23	4.07
P/TBV Ratio	2.35	2.35	6.42	-	-	-
P/FCF Ratio	2.80	1.02	-	3.56	171.97	3.09
P/OCF Ratio	2.40	0.97	-	3.37	56.10	2.73
EV/Sales Ratio	0.22	0.25	0.32	0.31	0.56	0.51
EV/EBITDA Ratio	3.02	3.64	5.48	5.87	31.51	-
EV/EBIT Ratio	3.28	3.89	5.86	6.50	50.14	-
EV/FCF Ratio	5.40	2.62	-	9.51	336.53	7.29
Debt / Equity Ratio	1.95	2.37	6.24	11.02	27.27	6.55
Debt / EBITDA Ratio	2.12	2.31	4.06	4.18	15.40	-
Debt / FCF Ratio	3.79	1.68	-	6.99	185.87	4.98
Asset Turnover	1.95	1.76	2.11	1.88	1.57	1.38
Inventory Turnover	7.29	7.19	9.75	11.55	11.73	7.58
Quick Ratio	0.69	0.79	0.70	0.61	0.57	0.59
Current Ratio	1.16	1.14	1.06	0.90	0.87	0.93
Return on Equity (ROE)	55.99%	59.25%	123.41%	122.11%	-122.33%	-91.35%
Return on Assets (ROA)	8.10%	7.05%	7.20%	5.60%	1.10%	-2.08%
Return on Capital (ROIC)	17.50%	14.70%	14.50%	11.60%	1.99%	-3.13%
Return on Capital Employed (ROCE)	40.40%	42.70%	48.40%	43.20%	8.70%	-
Earnings Yield	21.37%	21.17%	20.31%	7.58%	-14.48%	-46.20%
FCF Yield	35.78%	98.18%	-53.35%	28.09%	0.58%	32.34%
Buyback Yield / Dilution	-	-	-17.28%	-	-	1.70%
Total Shareholder Return	-	-	-17.28%	-	-	1.70%

Updated Dec 2, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.